Table 2: Univariate analysis of demographic and comorbidities in adult Covid-19 patients at NYU Langone Health from March 3 - May 31 2020 (N = 5473).

 Risk Factor

Male (N = 4036)

Female (N = 4288)

Sex p-value

Old (N = 3372)

Young (N = 4952)

Age p-value

White (N = 3421)

Black (N = 1455)

Asian (N = 616)

Other/Unknown (N = 2832)

Race p-value

Age < 60 yo

2221 (55.0)

2731 (63.7)

< 0.001

-

-

-

1681 (49.1)

922 (63.4)

372 (60.4)

1977 (69.8)

< 0.001

Female

-

-

-

1557 (46.2)

2731 (55.1)

< 0.001

1727 (50.5)

907 (62.3)

312 (50.6)

1342 (47.4)

< 0.001

HIV/AIDS

50 (1.2)

7 (0.2)

< 0.001

28 (0.8)

29 (0.6)

0.19**

15 (0.4)

9 (0.6)

1 (0.2)

32 (1.1)

0.003

Alcohol Misuse

115 (2.9)

17 (0.4)

< 0.001

43 (1.3)

89 (1.8)

0.063**

40 (1.2)

21 (1.4)

4 (0.7)

67 (2.4)

< 0.001

Asthma

318 (7.9)

480 (11.2)

< 0.001**

346 (10.3)

452 (9.1)

0.084

287 (8.4)

174 (12.0)

46 (7.5)

291 (10.3)

< 0.001**

Anemia

201 (5.0)

231 (5.4)

0.40

267 (7.9)

165 (3.3)

< 0.001**

206 (6.0)

83 (5.7)

33 (5.4)

110 (3.9)

0.002

Morbid Obesity (BMI > = 35)

520 (12.9)

740 (17.3)

0.001

440 (13.0)

820 (16.6)

< 0.001**

479 (14.0)

335 (23.0)

20 (3.2)

426 (15.0)

< 0.001

Cardiac Arrhythmia

1751 (43.4)

1188 (27.7)

< 0.001**

1899 (56.3)

1040 (21.0)

< 0.001**

1352 (39.5)

469 (32.2)

210 (34.1)

908 (32.1)

< 0.001

CHF

422 (10.5)

311 (7.3)

< 0.001**

612 (18.1)

121 (2.4)

< 0.001**

395 (11.5)

115 (7.9)

38 (6.2)

185 (6.5)

< 0.001

Cerebrovascular Disease

306 (7.6)

221 (5.2)

< 0.001

428 (12.7)

99 (2.0)

< 0.001**

260 (7.6)

93 (6.4)

33 (5.4)

141 (5.0)

< 0.001

Coagulopathy

577 (14.3)

318 (7.4)

< 0.001

607 (18.0)

288 (5.8)

< 0.001**

505 (14.8)

140 (9.6)

81 (13.1)

314 (11.1)

< 0.001*

CPD

594 (14.7)

712 (16.6)

0.018**

763 (22.6)

543 (11.0)

< 0.001

590 (17.2)

242 (16.6)

77 (12.5)

397 (14.0)

< 0.001

Cancer

276 (6.8)

243 (5.7)

0.027

405 (12.0)

114 (2.3)

< 0.001**

261 (7.6)

85 (5.8)

33 (5.4)

140 (4.9)

< 0.001**

Hematologic Malignancy

36 (0.9)

15 (0.3)

< 0.001

38 (1.1)

13 (0.3)

< 0.001

28 (0.8)

3 (0.2)

3 (0.5)

17 (0.6)

0.09

Solid Tumor (without Metastasis)

214 (5.3)

202 (4.7)

0.22

329 (9.8)

87 (1.8)

< 0.001

211 (6.2)

74 (5.1)

29 (4.7)

102 (3.6)

< 0.001**

Lymphoma

34 (0.8)

32 (0.7)

0.62*

50 (1.5)

16 (0.3)

< 0.001

32 (0.9)

10 (0.7)

2 (0.3)

22 (0.8)

0.42**

Dementia

184 (4.6)

225 (5.2)

0.15**

401 (11.9)

8 (0.2)

< 0.001

263 (7.7)

48 (3.3)

27 (4.4)

71 (2.5)

< 0.001*

Depression

350 (8.7)

428 (10.0)

0.041**

499 (14.8)

279 (5.6)

< 0.001

445 (13.0)

97 (6.7)

39 (6.3)

197 (7.0)

< 0.001

Diabetes with Complications

471 (11.7)

338 (7.9)

< 0.001

646 (19.2)

163 (3.3)

< 0.001**

333 (9.7)

173 (11.9)

53 (8.6)

250 (8.8)

0.010

Fluid and Electrolyte Disorders

1749 (43.3)

1096 (25.6)

< 0.001

1903 (56.4)

942 (19.0)

< 0.001**

1317 (38.5)

455 (31.3)

238 (38.6)

994 (35.1)

< 0.001**

HLD

1468 (36.4)

1163 (27.1)

< 0.001**

1916 (56.8)

715 (14.4)

< 0.001**

1298 (37.9)

451 (31.0)

186 (30.2)

696 (24.6)

< 0.001

HTN

1949 (48.3)

1510 (35.2)

< 0.001**

2464 (73.1)

995 (20.1)

< 0.001**

1559 (45.6)

700 (48.1)

247 (40.1)

953 (33.7)

< 0.001

Hypothyroidism

220 (5.5)

519 (12.1)

< 0.001

507 (15.0)

232 (4.7)

< 0.001

428 (12.5)

94 (6.5)

39 (6.3)

178 (6.3)

< 0.001

Liver Disease

278 (6.9)

155 (3.6)

< 0.001**

243 (7.2)

190 (3.8)

< 0.001**

190 (5.6)

56 (3.8)

38 (6.2)

149 (5.3)

0.059

Myocardial Infarction

350 (8.7)

188 (4.4)

< 0.001**

447 (13.3)

91 (1.8)

< 0.001**

536 (15.7)

189 (13.0)

78 (12.7)

304 (10.7)

< 0.001

Neurological Disorder

597 (14.8)

397 (9.3)

< 0.001**

770 (22.8)

224 (4.5)

< 0.001**

516 (15.1)

136 (9.3)

83 (13.5)

259 (9.1)

< 0.001

Paralysis

82 (2.0)

50 (1.2)

< 0.001**

86 (2.6)

46 (0.9)

< 0.001**

63 (1.8)

26 (1.8)

7 (1.1)

36 (1.3)

0.22

Psychoses

87 (2.2)

72 (1.7)

0.11

99 (2.9)

60 (1.2)

< 0.001

88 (2.6)

31 (2.1)

8 (1.3)

32 (1.1)

< 0.001

PUD

56 (1.4)

35 (0.8)

0.013

54 (1.6)

37 (0.7)

< 0.001**

43 (1.3)

17 (1.2)

4 (0.6)

27 (1.0)

0.46

Pulmonary Disorders

326 (8.1)

211 (4.9)

< 0.001**

381 (11.3)

156 (3.2)

< 0.001**

241 (7.0)

95 (6.5)

52 (8.4)

149 (5.3)

0.005

PV Disorders

367 (9.1)

217 (5.1)

< 0.001**

481 (14.3)

103 (2.1)

< 0.001**

310 (9.1)

108 (7.4)

27 (4.4)

139 (4.9)

< 0.001

Renal Disease

733 (18.2)

458 (10.7)

0.18**

940 (27.9)

251 (5.1)

< 0.001**

535 (15.6)

264 (18.1)

75 (12.2)

317 (11.2)

< 0.001

Renal Failure

669 (16.6)

420 (9.8)

< 0.001**

870 (25.8)

219 (4.4)

< 0.001**

491 (14.4)

238 (16.4)

67 (10.9)

293 (10.3)

< 0.001

Rheumatic Disease

48 (1.2)

147 (3.4)

< 0.001*

119 (3.5)

76 (1.5)

< 0.001

77 (2.3)

52 (3.6)

11 (1.8)

55 (1.9)

0.006

Smoking

171 (4.2)

98 (2.3)

< 0.001

100 (3.0)

169 (3.4)

0.063

110 (3.8)

62 (5.4)

12 (2.8)

85 (4.2)

0.058

Valvular Heart Disease

423 (10.5)

337 (7.9)

< 0.001

614 (18.2)

146 (2.9)

< 0.001**

411 (12.0)

102 (7.0)

60 (9.7)

187 (6.6)

< 0.001

Abbreviations: HIV/AIDS: Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome; CHF: Congestive Heart Failure; CPD: Chronic Pulmonary Disease; CPD: Chronic Pulmonary Disease; HLD: Hyperlipidemia; HTN: Hypertension; PUD: Peptic Ulcer Disease; PV: Peripheral Vascular.

*indicates comorbidities with a demographic modification significant at p-value < 0.10 for mortality risk; **indicates comorbidities with a demographic modification significant at p-value < 0.05 for mortality risk.